Discontinuing Statins in Older Adults without Cardiovascular Disease
Authors' conclusion
Among older adults with at least two chronic conditions but no known cardiovascular disease, discontinuation of statin therapy was noninferior to continuation with respect to major cardiovascular events or death from any cause at 2 years. (Funded by the Swiss National Science Foundation; STREAM ClinicalTrials.gov number, NCT05178420.).
Study context
- Population
- Adults at least 70 years of age with at least two chronic conditions but no known cardiovascular disease, taking statins for primary prevention
- Participants
- 1,880 adults
- Comparison
- Discontinue or continue statin therapy and other lipid-lowering therapies
- Discontinuation groupn = 938
- Continuation groupn = 942
- Primary endpoint
- Composite of:
- Nonfatal myocardial infarction
- Nonfatal ischemic stroke
- Death from any cause (restricted mean event-free survival time)
- Follow-up
- 2 years
Methodological detailsnoninferiority, 1:1 randomization
- Noninferiority
- 1:1 randomization
Primary result
As reported in the abstract
Composite of nonfatal myocardial infarction, nonfatal ischemic stroke, or death from any cause…
Discontinuation groupvs continuation group
difference in restricted mean event-free survival time −2.0 weeks (95% CI −3.7 to −0.3); P < 0.001 for noninferiority
Further findings
Baseline characteristics
- Mean age
- 77.5 years
- Women
- 46.9%
Safety
At least one serious adverse event
Original publication
Discontinuing Statins in Older Adults without Cardiovascular Disease. N Engl J Med. Published 7 November 2026. doi:10. 1056/ nejmoa2606634
Composed by AI from the published abstract and checked against it. How Briefs are made →